• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠体液中环磷酰胺代谢物的组织培养细胞毒性测定

Tissue culture cytotoxicity assay for cyclophosphamide metabolites in rat body fluids.

作者信息

Weaver F A, Torkelson A R, Zygmunt W A, Browder H P

出版信息

J Pharm Sci. 1978 Jul;67(7):1009-12. doi: 10.1002/jps.2600670738.

DOI:10.1002/jps.2600670738
PMID:660491
Abstract

An in vitro cytotoxicity assay for cyclophosphamide metabolites in rat body fluids is described. Of the two tissue culture tumor cell lines employed, the Walker-256 rat carcinosarcoma was more sensitive to metabolite levels than the L-1210 mouse lymphocytic leukemia. The Walker-256 system detected cyclophosphamide metabolite levels two orders of magnitude lower than the commonly used 4-(p-nitrobenzyl)pyridine analytical procedure.

摘要

本文描述了一种针对大鼠体液中环磷酰胺代谢物的体外细胞毒性测定方法。在所使用的两种组织培养肿瘤细胞系中,Walker-256大鼠癌肉瘤对代谢物水平的敏感性高于L-1210小鼠淋巴细胞白血病。Walker-256系统检测到的环磷酰胺代谢物水平比常用的4-(对硝基苄基)吡啶分析方法低两个数量级。

相似文献

1
Tissue culture cytotoxicity assay for cyclophosphamide metabolites in rat body fluids.大鼠体液中环磷酰胺代谢物的组织培养细胞毒性测定
J Pharm Sci. 1978 Jul;67(7):1009-12. doi: 10.1002/jps.2600670738.
2
Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.醛脱氢酶在环磷酰胺耐药性L1210白血病中的作用。
Cancer Res. 1984 Nov;44(11):5156-60.
3
Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
Arch Gynakol. 1977 Nov 29;223(4):249-57. doi: 10.1007/BF00667365.
4
Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo.体外和体内生成的环磷酰胺代谢产物的生物测定及相对细胞毒性效力
Cancer Res. 1973 Jun;33(6):1150-8.
5
Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard.沃克癌肉瘤256及其他啮齿动物肿瘤对环磷酰胺和L-苯丙氨酸氮芥的耐药模式。
Cancer Res. 1980 Mar;40(3):830-3.
6
Growth inhibitory activity of succinylacetone: studies with Walker 256 carcinosarcoma, Novikoff hepatoma and L1210 leukemia.琥珀酰丙酮的生长抑制活性:对沃克256癌肉瘤、诺维科夫肝癌和L1210白血病的研究
Oncology. 1983;40(2):148-54. doi: 10.1159/000225713.
7
A comparison of two cytotoxicity assays for the detection of metabolism-mediated toxicity in vitro: a study with cyclophosphamide.两种用于体外检测代谢介导毒性的细胞毒性试验的比较:以环磷酰胺为例的研究
Xenobiotica. 1985 Aug-Sep;15(8-9):681-6. doi: 10.3109/00498258509047427.
8
Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
Cancer Treat Rep. 1976 Apr;60(4):423-7.
9
[The effect of cyclophosphamide on tumors in the sensitivity-test (author's transl)].环磷酰胺对敏感性试验中肿瘤的作用(作者译)
Arch Gynakol. 1975;218(1):11-23. doi: 10.1007/BF00672279.
10
Metabolic activation and cytotoxicity of cyclophosphamide in primary cultures of postnatal rat hepatocytes.环磷酰胺在新生大鼠原代肝细胞培养中的代谢活化及细胞毒性
Biochem Pharmacol. 1981 Dec 1;30(23):3225-30. doi: 10.1016/0006-2952(81)90522-0.

引用本文的文献

1
Distribution and pharmacokinetics of cyclophosphamide in the rat.环磷酰胺在大鼠体内的分布及药代动力学
Br J Cancer. 1980 Jan;41(1):140-3. doi: 10.1038/bjc.1980.17.
2
A bioassay for cyclophosphamide in blood, lung and tumour.血液、肺和肿瘤中环磷酰胺的生物测定法。
Br J Cancer. 1984 Jan;49(1):49-55. doi: 10.1038/bjc.1984.8.
3
The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.放射增敏剂对小鼠体内美法仑和环磷酰胺药代动力学的影响。
Br J Cancer. 1983 Sep;48(3):375-83. doi: 10.1038/bjc.1983.202.
4
Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.氨苯砜生物活化成细胞毒性代谢物:使用含人体组织的新型双室系统进行体外研究。
Br J Clin Pharmacol. 1990 Sep;30(3):417-26. doi: 10.1111/j.1365-2125.1990.tb03793.x.
5
Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.静脉注射和口服后环磷酰胺在人体中的药代动力学及烷化活性
Br J Clin Pharmacol. 1979 Sep;8(3):209-17. doi: 10.1111/j.1365-2125.1979.tb01004.x.
6
Clinical pharmacokinetics of cyclophosphamide.环磷酰胺的临床药代动力学
Clin Pharmacokinet. 1979 Sep-Oct;4(5):380-94. doi: 10.2165/00003088-197904050-00004.